Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings
Authors
Keywords
-
Journal
AIDS Research and Therapy
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-16
DOI
10.1186/s12981-020-00298-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incomplete functional T-cell reconstitution in immunologic non-responders at one year after initiation of anti-retroviral therapy possibly predispose them to infectious diseases
- (2019) Ashwini Shete et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- HIV viral load point-of-care testing: the what, the whys and the wherefores
- (2018) Gary Brook SEXUALLY TRANSMITTED INFECTIONS
- Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring
- (2017) Trevor Peter et al. LANCET INFECTIOUS DISEASES
- Prevalence of discordant immunologic and virologic responses in patients with AIDS under antiretroviral therapy in a specialized care center in Brazil
- (2017) Janaina Aparecida Schineider Casotti et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- HIV infection and immune activation
- (2016) Afroditi Boulougoura et al. Current Opinion in HIV and AIDS
- Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
- (2016) Mohamed Abdel-Mohsen et al. PLoS Pathogens
- Galectin-9 Is Rapidly Released During Acute HIV-1 Infection and Remains Sustained at High Levels Despite Viral Suppression Even in Elite Controllers
- (2014) Ravi Tandon et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Circulating Biomarkers of Immune Activation Distinguish Viral Suppression from Nonsuppression in HAART-Treated Patients with Advanced HIV-1 Subtype C Infection
- (2014) Glen Malherbe et al. MEDIATORS OF INFLAMMATION
- Extraordinary Heterogeneity of Virological Outcomes in Patients Receiving Highly Antiretroviral Therapy and Monitored With the World Health Organization Public Health Approach in Sub-Saharan Africa and Southeast Asia
- (2013) A. F. Aghokeng et al. CLINICAL INFECTIOUS DISEASES
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
- (2013) Stephanie Jost et al. Retrovirology
- Reactivation of latent HIV-1 in central memory CD4+ T cells through TLR-1/2 stimulation
- (2013) Camille L Novis et al. Retrovirology
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- HIV-1 Is Not a Major Driver of Increased Plasma IL-6 Levels in Chronic HIV-1 Disease
- (2012) Carey L. Shive et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Influence of Galectin-9/Tim-3 Interaction on Herpes Simplex Virus-1 Latency
- (2011) P. B. J. Reddy et al. JOURNAL OF IMMUNOLOGY
- Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells
- (2011) Michael M. Lederman et al. JOURNAL OF INFECTIOUS DISEASES
- Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
- (2011) Netanya G. Sandler et al. JOURNAL OF INFECTIOUS DISEASES
- Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses
- (2011) C Rollenhagen et al. Mucosal Immunology
- T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses
- (2011) S. Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Change in High-Sensitivity C-Reactive Protein Levels Following Initiation of Efavirenz-Based Antiretroviral Regimens in HIV-Infected Individuals
- (2010) Cecilia M. Shikuma et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
- (2010) John A. Mengshol et al. PLoS One
- Viremia, Resuppression, and Time to Resistance in Human Immunodeficiency Virus (HIV) Subtype C during First‐Line Antiretroviral Therapy in South Africa
- (2009) Christopher J. Hoffmann et al. CLINICAL INFECTIOUS DISEASES
- Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with
- (2009) Silvia Baroncelli et al. JOURNAL OF CLINICAL VIROLOGY
- Relevance of CD38 Expression on CD8 T Cells to Evaluate Antiretroviral Therapy Response in HIV-1-infected Youths
- (2009) R. Rosso et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now